Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Uterine Cervical Neoplasms 3Vaginal Neoplasms 2Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neuroendocrine Tumors 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Accelerated Phase 1Gallbladder Neoplasms 1Blast Crisis 1

Interventions

fludarabine phosphate 32Peripheral Blood Stem Cell Transplantation 27Tacrolimus 26Cyclophosphamide 26Whole-Body Irradiation 25Busulfan 21Mycophenolic Acid 20Methotrexate 16Antilymphocyte Serum 16Melphalan 12Cyclosporine 9Cord Blood Stem Cell Transplantation 8Filgrastim 7Etoposide 7Thiotepa 6thymoglobulin 5merphos 5Sirolimus 5Rituximab 5Radiotherapy 5Methylprednisolone 5Cytarabine 5Granulocyte Colony-Stimulating Factor 4sargramostim 3fludarabine 3Flow Cytometry 3Transplantation 2Polymerase Chain Reaction 2Ondansetron 2Imatinib Mesylate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Myeloid, Accelerated Phase × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × Clear all
NCT00381550 2015-01-06

3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
35 enrolled 8 charts
MyeloidOther hematologic neoplasm

Pdgfra-Associated Chronic Eosinophilic Leukemia, Blast Crisis, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡